LGC Limited

LGC announced its acquisition of Technopath Clinical Diagnostics, expanding LGC's position in the clinical diagnostics QC market. Technopath's chemistry and immunoassay controls will be integrated into LGC's clinical diagnostics business unit.

LGC Group has acquired Toronto Research Chemicals, a company producing synthetic organic biochemicals used as reference standards.

LGC Limited completed the acquisition of US-based life sciences and healthcare products provider Lucigen Corporation.